ND SB2094

Defines "telemedicine" as the practice of medicine using electronic communication or information technologies between a licensee and patient in different locations, including direct interactive encounters, asynchronous store-and-forward technologies, and remote monitoring.

Requires telemedicine practitioners to establish a bona fide patient relationship, verify patient and provider identity, and perform an examination equivalent to in-person care before diagnosis or treatment, with exceptions for certain asynchronous technologies like teleradiology.

Prohibits prescription of opioids through telemedicine except for FDA-approved medication-assisted treatment for opioid use disorder or treatment of patients in hospitals or long-term care facilities.

Transfers regulation of fluoroscopy technologists from the North Dakota Board of Medicine to the North Dakota Medical Imaging and Radiation Therapy Board, effective August 1, 2019, with automatic license transfer for technologists in good standing.

Limits fluoroscopy technologist scope of practice to gastrointestinal fluoroscopy and requires supervision by a primary supervising physician, with continuing education requirements including at least six hours on fluoroscopy safety and radiation protection for biennial renewal.